9 Meters Biopharma Ownership 2024 | Who Owns 9 Meters Biopharma Now?
Institutional Ownership
0.00%
Insider Ownership
1.71%
Retail Ownership
98.29%
Institutional Holders
1.00
9 Meters Biopharma Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| SABBY MANAGEMENT, LLC | 8.52% | 1.34% | 1,103,645 | 1,103,645 | 100.00% | 1,534,067,000 | Mar 31, 2023 |
| SIMPLEX TRADING, LLC | 5.40% | 0.00% | 699,500 | -82,300 | -10.53% | 972,000 | Mar 31, 2023 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 5.02% | 0.00% | 650,000 | - | - | 903,500,000 | Mar 31, 2023 |
| VANGUARD GROUP INC | 4.85% | - | 628,306 | - | - | 873,345,000 | Mar 31, 2023 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 3.72% | 0.00% | 482,300 | -29,300 | -5.73% | 670,397,000 | Mar 31, 2023 |
| LAURION CAPITAL MANAGEMENT LP | 1.76% | 0.00% | 227,910 | - | - | 316,795,000 | Mar 31, 2023 |
| BLACKROCK INC. | 1.30% | - | 168,039 | -145 | -0.09% | 233,574,000 | Mar 31, 2023 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.84% | - | 108,824 | -1 | -0.00% | 151,265,000 | Mar 31, 2023 |
| STATE STREET CORP | 0.39% | - | 50,908 | - | - | 70,762,000 | Mar 31, 2023 |
| ODONNELL FINANCIAL SERVICES, LLC | 0.34% | 0.11% | 43,410 | - | - | 60,340,000 | Mar 31, 2023 |
| COMMONWEALTH EQUITY SERVICES, LLC | 0.29% | 0.00% | 37,885 | -256 | -0.67% | 52,000 | Mar 31, 2023 |
| CIBC ASSET MANAGEMENT INC | 0.25% | 0.00% | 32,722 | 32,722 | 100.00% | 45,484,000 | Mar 31, 2023 |
| CITADEL ADVISORS LLC | 0.20% | - | 25,900 | 13,730 | 112.82% | 36,001,000 | Mar 31, 2023 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.18% | - | 23,500 | -1,000 | -4.08% | 32,665,000 | Mar 31, 2023 |
| NORTHERN TRUST CORP | 0.17% | - | 21,461 | -46 | -0.21% | 29,831,000 | Mar 31, 2023 |
| HRT FINANCIAL LP | 0.14% | 0.00% | 18,249 | -24,281 | -57.09% | 25,000 | Mar 31, 2023 |
| DIMENSIONAL FUND ADVISORS LP | 0.13% | - | 16,264 | -255 | -1.54% | 22,607,000 | Mar 31, 2023 |
| MILLENNIUM MANAGEMENT LLC | 0.12% | - | 15,326 | -24,763 | -61.77% | 21,000 | Mar 31, 2023 |
| REQUISITE CAPITAL MANAGEMENT, LLC | 0.12% | 0.01% | 15,000 | 15,000 | 100.00% | 20,850,000 | Mar 31, 2023 |
| RENAISSANCE TECHNOLOGIES LLC | 0.11% | - | 14,325 | -58,843 | -80.42% | 20,000 | Mar 31, 2023 |
9 Meters Biopharma's largest institutional shareholder is SABBY MANAGEMENT, LLC, holding 8.52% of the company's total share outstanding, currently valued at $1.53B. The top 10 institutional shareholders own together 32.13% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| SABBY MANAGEMENT, LLC | 8.52% | 1.34% | 1,103,645 | 1,103,645 | 100.00% | 1,534,067,000 | Mar 31, 2023 |
| ODONNELL FINANCIAL SERVICES, LLC | 0.34% | 0.11% | 43,410 | - | - | 60,340,000 | Mar 31, 2023 |
| REQUISITE CAPITAL MANAGEMENT, LLC | 0.12% | 0.01% | 15,000 | 15,000 | 100.00% | 20,850,000 | Mar 31, 2023 |
| LAURION CAPITAL MANAGEMENT LP | 1.76% | 0.00% | 227,910 | - | - | 316,795,000 | Mar 31, 2023 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 5.02% | 0.00% | 650,000 | - | - | 903,500,000 | Mar 31, 2023 |
| SIMPLEX TRADING, LLC | 5.40% | 0.00% | 699,500 | -82,300 | -10.53% | 972,000 | Mar 31, 2023 |
| HRT FINANCIAL LP | 0.14% | 0.00% | 18,249 | -24,281 | -57.09% | 25,000 | Mar 31, 2023 |
| TOWER RESEARCH CAPITAL LLC (TRC) | 0.04% | 0.00% | 5,008 | 4,295 | 602.38% | 7,000 | Mar 31, 2023 |
| PSI ADVISORS, LLC | 0.00% | 0.00% | 300 | - | - | 417,000 | Mar 31, 2023 |
| CIBC ASSET MANAGEMENT INC | 0.25% | 0.00% | 32,722 | 32,722 | 100.00% | 45,484,000 | Mar 31, 2023 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 3.72% | 0.00% | 482,300 | -29,300 | -5.73% | 670,397,000 | Mar 31, 2023 |
| REGISTER FINANCIAL ADVISORS LLC | 0.00% | 0.00% | 100 | - | - | 139,000 | Mar 31, 2023 |
| COMMONWEALTH EQUITY SERVICES, LLC | 0.29% | 0.00% | 37,885 | -256 | -0.67% | 52,000 | Mar 31, 2023 |
| STRATEGIC INVESTMENT SOLUTIONS, INC. /IL | 0.00% | 0.00% | 275 | 275 | 100.00% | 382,000 | Mar 31, 2023 |
| HARTFORD FINANCIAL MANAGEMENT INC. | 0.00% | 0.00% | 200 | - | - | 278,000 | Mar 31, 2023 |
| MERCER GLOBAL ADVISORS INC /ADV | 0.08% | 0.00% | 10,250 | 10,250 | 100.00% | 14,000 | Mar 31, 2023 |
| BEACON CAPITAL MANAGEMENT, LLC | 0.00% | 0.00% | 155 | - | - | 215,000 | Mar 31, 2023 |
| MCF ADVISORS LLC | 0.00% | - | 275 | - | - | 383,000 | Mar 31, 2023 |
| CERITY PARTNERS LLC | 0.08% | - | 10,708 | 10,708 | 100.00% | 14,884,000 | Mar 31, 2023 |
| GROUP ONE TRADING, L.P. | 0.04% | - | 5,363 | -6,009 | -52.84% | 7,455,000 | Mar 31, 2023 |
The largest 9 Meters Biopharma shareholder by % of total assets is SABBY MANAGEMENT, LLC. The company owns 1.10M shares of 9 Meters Biopharma (NMTR), representing 1.34% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| SABBY MANAGEMENT, LLC | 8.52% | 1.34% | 1,103,645 | 1,103,645 | 100.00% | 1,534,067,000 | Mar 31, 2023 |
| CIBC ASSET MANAGEMENT INC | 0.25% | 0.00% | 32,722 | 32,722 | 100.00% | 45,484,000 | Mar 31, 2023 |
| REQUISITE CAPITAL MANAGEMENT, LLC | 0.12% | 0.01% | 15,000 | 15,000 | 100.00% | 20,850,000 | Mar 31, 2023 |
| CITADEL ADVISORS LLC | 0.20% | - | 25,900 | 13,730 | 112.82% | 36,001,000 | Mar 31, 2023 |
| CERITY PARTNERS LLC | 0.08% | - | 10,708 | 10,708 | 100.00% | 14,884,000 | Mar 31, 2023 |
| MERCER GLOBAL ADVISORS INC /ADV | 0.08% | 0.00% | 10,250 | 10,250 | 100.00% | 14,000 | Mar 31, 2023 |
| CITADEL ADVISORS LLC | 0.09% | - | 11,900 | 8,735 | 275.99% | 16,541,000 | Mar 31, 2023 |
| TOWER RESEARCH CAPITAL LLC (TRC) | 0.04% | 0.00% | 5,008 | 4,295 | 602.38% | 7,000 | Mar 31, 2023 |
| STRATEGIC INVESTMENT SOLUTIONS, INC. /IL | 0.00% | 0.00% | 275 | 275 | 100.00% | 382,000 | Mar 31, 2023 |
| BANK OF AMERICA CORP /DE/ | 0.04% | - | 5,733 | 135 | 2.41% | 7,969,000 | Mar 31, 2023 |
| WELLS FARGO & COMPANY/MN | 0.00% | - | 340 | 2 | 0.59% | 473,000 | Mar 31, 2023 |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | - | - | 2 | - | - | 3,000 | Mar 31, 2023 |
| PNC FINANCIAL SERVICES GROUP, INC. | 0.00% | - | 150 | - | - | 209,000 | Mar 31, 2023 |
| ADVISOR GROUP HOLDINGS, INC. | 0.00% | - | 600 | - | - | 833,000 | Mar 31, 2023 |
| STATE STREET CORP | 0.39% | - | 50,908 | - | - | 70,762,000 | Mar 31, 2023 |
| TCI WEALTH ADVISORS, INC. | 0.00% | - | 50 | - | - | 70,000 | Mar 31, 2023 |
| VANGUARD GROUP INC | 4.85% | - | 628,306 | - | - | 873,345,000 | Mar 31, 2023 |
| STEWARD PARTNERS INVESTMENT ADVISORY, LLC | 0.01% | - | 1,117 | - | - | 1,553,000 | Mar 31, 2023 |
| MCF ADVISORS LLC | 0.00% | - | 275 | - | - | 383,000 | Mar 31, 2023 |
| BEACON CAPITAL MANAGEMENT, LLC | 0.00% | 0.00% | 155 | - | - | 215,000 | Mar 31, 2023 |
As of Mar 31 2023, 9 Meters Biopharma's largest institutional buyer is SABBY MANAGEMENT, LLC. The company purchased 1.10M stocks of NMTR, valued at $1.53B.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| GSA CAPITAL PARTNERS LLP | - | - | - | -109,685 | -100.00% | - | Mar 31, 2023 |
| SIMPLEX TRADING, LLC | 5.40% | 0.00% | 699,500 | -82,300 | -10.53% | 972,000 | Mar 31, 2023 |
| RENAISSANCE TECHNOLOGIES LLC | 0.11% | - | 14,325 | -58,843 | -80.42% | 20,000 | Mar 31, 2023 |
| TWO SIGMA INVESTMENTS, LP | - | - | - | -47,617 | -100.00% | - | Mar 31, 2023 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 3.72% | 0.00% | 482,300 | -29,300 | -5.73% | 670,397,000 | Mar 31, 2023 |
| HUDSON BAY CAPITAL MANAGEMENT LP | - | - | - | -25,001 | -100.00% | - | Mar 31, 2023 |
| MERIT FINANCIAL GROUP, LLC | - | - | - | -25,000 | -100.00% | - | Mar 31, 2023 |
| MILLENNIUM MANAGEMENT LLC | 0.12% | - | 15,326 | -24,763 | -61.77% | 21,000 | Mar 31, 2023 |
| HRT FINANCIAL LP | 0.14% | 0.00% | 18,249 | -24,281 | -57.09% | 25,000 | Mar 31, 2023 |
| ADVISER INVESTMENTS LLC | - | - | - | -21,429 | -100.00% | - | Mar 31, 2023 |
| UBS GROUP AG | 0.03% | - | 4,340 | -7,989 | -64.80% | 6,033,000 | Mar 31, 2023 |
| GROUP ONE TRADING, L.P. | 0.04% | - | 5,000 | -6,900 | -57.98% | 6,950,000 | Mar 31, 2023 |
| GROUP ONE TRADING, L.P. | 0.04% | - | 5,363 | -6,009 | -52.84% | 7,455,000 | Mar 31, 2023 |
| SIMPLEX TRADING, LLC | - | - | - | -1,500 | -100.00% | - | Mar 31, 2023 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.18% | - | 23,500 | -1,000 | -4.08% | 32,665,000 | Mar 31, 2023 |
| ROCKEFELLER CAPITAL MANAGEMENT L.P. | - | - | - | -1,000 | -100.00% | - | Mar 31, 2023 |
| MORGAN STANLEY | 0.02% | - | 2,582 | -572 | -18.14% | 3,589,000 | Mar 31, 2023 |
| SABBY MANAGEMENT, LLC | - | - | - | -543 | -100.00% | - | Mar 31, 2023 |
| COMMONWEALTH EQUITY SERVICES, LLC | 0.29% | 0.00% | 37,885 | -256 | -0.67% | 52,000 | Mar 31, 2023 |
| DIMENSIONAL FUND ADVISORS LP | 0.13% | - | 16,264 | -255 | -1.54% | 22,607,000 | Mar 31, 2023 |
As of Mar 31 2023, 9 Meters Biopharma's biggest institutional seller is GSA CAPITAL PARTNERS LLP. The company sold -0.11M shares of NMTR, valued at -.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| SABBY MANAGEMENT, LLC | 8.52% | 1.34% | 1,103,645 | 1,103,645 | 100.00% | 1,534,067,000 | Mar 31, 2023 |
| CIBC ASSET MANAGEMENT INC | 0.25% | 0.00% | 32,722 | 32,722 | 100.00% | 45,484,000 | Mar 31, 2023 |
| REQUISITE CAPITAL MANAGEMENT, LLC | 0.12% | 0.01% | 15,000 | 15,000 | 100.00% | 20,850,000 | Mar 31, 2023 |
| CERITY PARTNERS LLC | 0.08% | - | 10,708 | 10,708 | 100.00% | 14,884,000 | Mar 31, 2023 |
| MERCER GLOBAL ADVISORS INC /ADV | 0.08% | 0.00% | 10,250 | 10,250 | 100.00% | 14,000 | Mar 31, 2023 |
| STRATEGIC INVESTMENT SOLUTIONS, INC. /IL | 0.00% | 0.00% | 275 | 275 | 100.00% | 382,000 | Mar 31, 2023 |
9 Meters Biopharma's largest new institutional shareholder by number of shares is SABBY MANAGEMENT, LLC, purchased 1.10M shares, valued at $1.53B, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| GSA CAPITAL PARTNERS LLP | - | - | - | -109,685 | -100.00% | - | Mar 31, 2023 |
| TWO SIGMA INVESTMENTS, LP | - | - | - | -47,617 | -100.00% | - | Mar 31, 2023 |
| HUDSON BAY CAPITAL MANAGEMENT LP | - | - | - | -25,001 | -100.00% | - | Mar 31, 2023 |
| MERIT FINANCIAL GROUP, LLC | - | - | - | -25,000 | -100.00% | - | Mar 31, 2023 |
| ADVISER INVESTMENTS LLC | - | - | - | -21,429 | -100.00% | - | Mar 31, 2023 |
| SIMPLEX TRADING, LLC | - | - | - | -1,500 | -100.00% | - | Mar 31, 2023 |
| ROCKEFELLER CAPITAL MANAGEMENT L.P. | - | - | - | -1,000 | -100.00% | - | Mar 31, 2023 |
| SABBY MANAGEMENT, LLC | - | - | - | -543 | -100.00% | - | Mar 31, 2023 |
| GROUP ONE TRADING, L.P. | - | - | - | -100 | -100.00% | - | Mar 31, 2023 |
9 Meters Biopharma's largest sold out institutional shareholder by shares sold is GSA CAPITAL PARTNERS LLP, sold -0.11M shares, valued at -, as of undefined.
9 Meters Biopharma Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.05% | 32,519 | - | - | Mar 31, 2024 |
| QUANTITATIVE MASTER SERIES LLC | 0.05% | 312,482 | - | - | Mar 31, 2024 |
| VANGUARD INDEX FUNDS | 0.03% | 12,131,400 | - | - | Mar 31, 2024 |
| TIAA SEPARATE ACCOUNT VA 1 | 0.03% | 6,325 | - | - | Mar 31, 2024 |
| VANGUARD VALLEY FORGE FUNDS | 0.02% | 8,477 | - | - | Mar 31, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.01% | 2,013,233 | - | - | Feb 29, 2024 |
| Calvert Variable Products, Inc. | 0.01% | 16,663 | - | - | Mar 31, 2024 |
| VANGUARD VARIABLE INSURANCE FUNDS | 0.01% | 318,323 | - | - | Mar 31, 2024 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.01% | 175,410 | - | - | Mar 31, 2024 |
| Chartwell Funds | 0.00% | 86,748 | - | - | Jun 30, 2022 |
| SCHWAB CAPITAL TRUST | 0.00% | 107,754 | - | - | Feb 29, 2024 |
| Voya VARIABLE PORTFOLIOS INC | 0.00% | 80,326 | - | - | Mar 31, 2024 |
| Principal Exchange-Traded Funds | 0.00% | 28,865 | - | - | Mar 31, 2024 |
| STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 0.00% | 7,734 | - | - | Mar 31, 2024 |
| TIAA-CREF LIFE FUNDS | 0.00% | 4,288 | - | - | Mar 31, 2024 |
| VANGUARD INDEX FUNDS | 0.00% | 606,825 | - | - | Mar 31, 2024 |
| Global X Funds | 0.00% | 64,156 | - | - | Jan 31, 2024 |
| COLLEGE RETIREMENT EQUITIES FUND | 0.00% | 1,517,720 | - | - | Mar 31, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND II | 0.00% | 11,939 | - | - | Mar 31, 2024 |
| NORTHERN FUNDS | 0.00% | 115,184 | - | - | Mar 28, 2024 |
| STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 44,200 | - | - | Mar 31, 2024 |
| RYDEX SERIES FUNDS | 0.00% | 2,157 | - | - | Dec 31, 2023 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 99,321 | - | - | Feb 29, 2024 |
| EQ ADVISORS TRUST | 0.00% | 511,366 | - | - | Mar 31, 2024 |
| T. Rowe Price Index Trust, Inc. | 0.00% | 9,555 | - | - | Feb 29, 2024 |
| ProFunds | 0.00% | 4,842 | - | - | Mar 31, 2024 |
| FIDELITY SALEM STREET TRUST | 0.00% | 1,615,070 | - | - | Mar 31, 2024 |
| VANGUARD SCOTTSDALE FUNDS | 0.00% | 772,642 | - | - | Feb 29, 2024 |
| FLEXSHARES TRUST | 0.00% | 29,516 | - | - | Jan 31, 2024 |
| RYDEX DYNAMIC FUNDS | 0.00% | 1,194 | - | - | Dec 31, 2023 |
| VALIC Co I | 0.00% | 83,918 | - | - | Feb 29, 2024 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 8,771 | - | - | Mar 31, 2024 |
| PENN SERIES FUNDS INC | 0.00% | 8,200 | - | - | Mar 28, 2024 |
| Guggenheim Active Allocation Fund | 0.00% | 1,334 | - | - | Feb 29, 2024 |
| NATIONWIDE VARIABLE INSURANCE TRUST | 0.00% | 28,347 | - | - | Mar 31, 2024 |
| TIAA-CREF FUNDS | 0.00% | 585,908 | - | - | Mar 31, 2024 |
| RYDEX VARIABLE TRUST | 0.00% | 215 | - | - | Dec 31, 2023 |
| NATIONWIDE MUTUAL FUNDS | 0.00% | 21,694 | - | - | Jan 31, 2024 |
| PROSHARES TRUST | 0.00% | 32,637 | - | - | Feb 29, 2024 |
| USAA MUTUAL FUNDS TRUST | 0.00% | 28,830 | - | - | Jan 31, 2024 |
| Brighthouse Funds Trust II | 0.00% | 84,767 | - | - | Mar 31, 2024 |
| MORGAN STANLEY PATHWAY FUNDS | 0.00% | 8,548 | - | - | Feb 29, 2024 |
| LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 188,600 | - | - | Mar 31, 2024 |
| ETF Series Solutions | 0.00% | 1,472 | - | - | Jan 31, 2024 |
| SUNAMERICA SERIES TRUST | 0.00% | 24,965 | - | - | Mar 31, 2024 |
| JOHN HANCOCK VARIABLE INSURANCE TRUST | 0.00% | 104,423 | - | - | Mar 31, 2024 |
| Dimensional ETF Trust | 0.00% | 11,364 | - | - | Jan 31, 2024 |
| Blackstone Alternative Investment Funds | 0.00% | 1,300 | - | - | Mar 31, 2023 |
| PACIFIC SELECT FUND | 0.00% | 74,035 | - | - | Mar 31, 2024 |
| MASSMUTUAL SELECT FUNDS | 0.00% | 19,815 | - | - | Dec 31, 2023 |
| iSHARES TRUST | 0.00% | 106,503 | - | - | Mar 31, 2024 |
| Bridge Builder Trust | 0.00% | 29,996 | - | - | Mar 31, 2024 |
| USAA MUTUAL FUNDS TRUST | 0.00% | 1,437 | - | - | Jan 31, 2024 |
| BlackRock Variable Series Funds, Inc. | 0.00% | 25,349 | - | - | Mar 31, 2024 |
| PRINCIPAL FUNDS, INC. | 0.00% | 33,923 | - | - | Feb 29, 2024 |
| BLACKROCK FUNDS | 0.00% | 29,422 | - | - | Mar 28, 2024 |
| SEI INSTITUTIONAL INVESTMENTS TRUST | 0.00% | 45,400 | - | - | Feb 29, 2024 |
| DFA INVESTMENT DIMENSIONS GROUP INC | 0.00% | 1,830 | - | - | Jan 31, 2024 |
| John Hancock Funds II | 0.00% | 26,293 | - | - | Feb 29, 2024 |
| iSHARES TRUST | 0.00% | 4,851 | - | - | Mar 31, 2024 |
| Meeder Funds | 0.00% | 1 | - | - | Mar 31, 2024 |
| JOHN HANCOCK VARIABLE INSURANCE TRUST | 0.00% | 371 | - | - | Mar 31, 2024 |
| AQR Funds | 0.00% | 108,293 | - | - | Mar 31, 2024 |
9 Meters Biopharma's largest mutual fund holder by % of total assets is "DEUTSCHE DWS INVESTMENTS VIT FUNDS", owning 32.52K shares, compromising 0.05% of its total assets.
9 Meters Biopharma Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 31 Dec, 22 | 1 | -98.53% |
| 30 Sep, 22 | 68 | -16.05% |
| 30 Jun, 22 | 81 | -15.63% |
| 31 Mar, 22 | 96 | -9.43% |
| 31 Dec, 21 | 106 | -1.85% |
| 30 Sep, 21 | 108 | 6.93% |
| 30 Jun, 21 | 101 | 14.77% |
| 31 Mar, 21 | 88 | 51.72% |
| 31 Dec, 20 | 58 | 38.10% |
| 30 Sep, 20 | 42 | 55.56% |
| 30 Jun, 20 | 27 | - |
As of 31 Dec 22, 1 institutions are holding 9 Meters Biopharma's shares, representing a decrease of -98.53% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 31 Dec, 22 | 101 | -100.00% |
| 30 Sep, 22 | 48,009,180 | -17.32% |
| 30 Jun, 22 | 58,066,820 | -22.93% |
| 31 Mar, 22 | 75,341,924 | -4.32% |
| 31 Dec, 21 | 78,743,779 | 8.65% |
| 30 Sep, 21 | 72,471,726 | -2.47% |
| 30 Jun, 21 | 74,308,960 | 0.87% |
| 31 Mar, 21 | 73,671,196 | 21.31% |
| 31 Dec, 20 | 60,727,489 | 103.03% |
| 30 Sep, 20 | 29,910,239 | 4.46% |
| 30 Jun, 20 | 28,633,597 | - |
9 Meters Biopharma (NMTR) has 101.00 shares outstanding as of 31 Dec 22, down -100.00% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 31 Dec, 22 | 0.00% | - |
| 30 Sep, 22 | 18.53% | 3.69% |
| 30 Jun, 22 | 22.42% | 2.63% |
| 31 Mar, 22 | 29.18% | 3.04% |
| 31 Dec, 21 | 30.97% | 3.81% |
| 30 Sep, 21 | 28.50% | 3.21% |
| 30 Jun, 21 | 29.78% | 2.45% |
| 31 Mar, 21 | 34.87% | 1.90% |
| 31 Dec, 20 | 42.88% | 9.61% |
| 30 Sep, 20 | 21.12% | 1.59% |
| 30 Jun, 20 | 36.44% | - |
As of 31 Dec 22, 9 Meters Biopharma is held by 0.00% institutional shareholders, representing a 0.00% growth compared to 30 Sep 22.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 31 Dec, 22 | 1 | -96.43% |
| 30 Sep, 22 | 28 | -22.22% |
| 30 Jun, 22 | 36 | 28.57% |
| 31 Mar, 22 | 28 | -34.88% |
| 31 Dec, 21 | 43 | -8.51% |
| 30 Sep, 21 | 47 | -24.19% |
| 30 Jun, 21 | 62 | 1.64% |
| 31 Mar, 21 | 61 | 60.53% |
| 31 Dec, 20 | 38 | 2.70% |
| 30 Sep, 20 | 37 | 42.31% |
| 30 Jun, 20 | 26 | - |
1 institutional shareholders have increased their position in NMTR stock as of 31 Dec 22 compared to 28 in the previous quarter (a -96.43% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 31 Dec, 22 | - | -100.00% |
| 30 Sep, 22 | 17 | 13.33% |
| 30 Jun, 22 | 15 | -51.61% |
| 31 Mar, 22 | 31 | 10.71% |
| 31 Dec, 21 | 28 | 40.00% |
| 30 Sep, 21 | 20 | 42.86% |
| 30 Jun, 21 | 14 | 16.67% |
| 31 Mar, 21 | 12 | 140.00% |
| 31 Dec, 20 | 5 | 400.00% |
| 30 Sep, 20 | 1 | - |
| 30 Jun, 20 | - | - |
- institutional shareholders have reduced their position in NMTR stock as of 31 Dec 22 compared to 17 in the previous quarter (a -100.00% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 31 Dec, 22 | 1 | -98.53% | 101 | -100.00% | 0.00% | - | 1 | -96.43% | - | -100.00% |
| 30 Sep, 22 | 68 | -16.05% | 48,009,180 | -17.32% | 18.53% | 3.69% | 28 | -22.22% | 17 | 13.33% |
| 30 Jun, 22 | 81 | -15.63% | 58,066,820 | -22.93% | 22.42% | 2.63% | 36 | 28.57% | 15 | -51.61% |
| 31 Mar, 22 | 96 | -9.43% | 75,341,924 | -4.32% | 29.18% | 3.04% | 28 | -34.88% | 31 | 10.71% |
| 31 Dec, 21 | 106 | -1.85% | 78,743,779 | 8.65% | 30.97% | 3.81% | 43 | -8.51% | 28 | 40.00% |
| 30 Sep, 21 | 108 | 6.93% | 72,471,726 | -2.47% | 28.50% | 3.21% | 47 | -24.19% | 20 | 42.86% |
| 30 Jun, 21 | 101 | 14.77% | 74,308,960 | 0.87% | 29.78% | 2.45% | 62 | 1.64% | 14 | 16.67% |
| 31 Mar, 21 | 88 | 51.72% | 73,671,196 | 21.31% | 34.87% | 1.90% | 61 | 60.53% | 12 | 140.00% |
| 31 Dec, 20 | 58 | 38.10% | 60,727,489 | 103.03% | 42.88% | 9.61% | 38 | 2.70% | 5 | 400.00% |
| 30 Sep, 20 | 42 | 55.56% | 29,910,239 | 4.46% | 21.12% | 1.59% | 37 | 42.31% | 1 | - |
| 30 Jun, 20 | 27 | - | 28,633,597 | - | 36.44% | - | 26 | - | - | - |
9 Meters Biopharma Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
Insider Sells
All Insider Owners Trades
The last insider sell of 9 Meters Biopharma's stock was made by Sensenig Bethany on Apr 21 2023, selling 9,100 shares at $1.21 per share (valued at $11.01K). The last insider buy of NMTR was made by Temperato John on Jul 08 2022, buying 125,000 shares at $0.23 per share (worth $28.46K).
9 Meters Biopharma Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q2 2023 | - | 1 | - |
| Q1 2023 | 7 | - | - |
| Q3 2022 | 3 | - | - |
| Q2 2022 | 8 | - | - |
| Q1 2022 | 4 | - | - |
| Q4 2021 | 4 | - | - |
| Q3 2021 | 5 | - | - |
| Q2 2021 | 10 | 3 | 333.33% |
| Q1 2021 | 3 | - | - |
| Q4 2020 | 10 | 2 | 500.00% |
| Q3 2020 | 17 | - | - |
| Q2 2020 | 38 | 9 | 422.22% |
| Q3 2019 | 3 | - | - |
| Q2 2019 | 10 | - | - |
| Q4 2018 | 13 | - | - |
| Q3 2018 | 17 | - | - |
| Q2 2018 | - | - | - |
| Q1 2018 | 5 | 9 | 55.56% |
| Q4 2017 | 5 | - | - |
| Q3 2017 | 3 | - | - |
0 total buy trades, and 1 total sell trades (buy/sell ratio of 0.00%) were made by 9 Meters Biopharma's insiders, as of Q2 2023.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q2 2023 | - | 1 | - |
| Q1 2023 | - | - | - |
| Q3 2022 | 2 | - | - |
| Q2 2022 | 3 | - | - |
| Q1 2022 | 2 | - | - |
| Q4 2021 | 3 | - | - |
| Q3 2021 | 5 | - | - |
| Q2 2021 | 3 | 3 | 100.00% |
| Q1 2021 | - | - | - |
| Q4 2020 | 3 | - | - |
| Q3 2020 | 8 | - | - |
| Q2 2020 | 17 | - | - |
| Q3 2019 | - | - | - |
| Q2 2019 | 6 | - | - |
| Q4 2018 | 7 | - | - |
| Q3 2018 | 17 | - | - |
| Q2 2018 | - | - | - |
| Q1 2018 | 1 | - | - |
| Q4 2017 | 1 | - | - |
| Q3 2017 | - | - | - |
As of Q2 2023, Insider owners conducted 0 open market buy trades and 1 open market sell trades of 9 Meters Biopharma's stocks.
9 Meters Biopharma Peer Ownership
| Ticker | Company |
|---|---|
| MGTA | Dianthus Therapeutics, Inc. |
| MREO | Mereo BioPharma Group plc |
| IKNA | Ikena Oncology, Inc. |
| DAWN | Day One Biopharmaceuticals, Inc. |
| HSTO | Histogen Inc. |
| ARTL | Artelo Biosciences, Inc. |
| MEIP | MEI Pharma, Inc. |
| INZY | Inozyme Pharma, Inc. |
| KA | Kineta, Inc. |
| ALVR | AlloVir, Inc. |
| ABOS | Acumen Pharmaceuticals, Inc. |
| RNXT | RenovoRx, Inc. |
| CADL | Candel Therapeutics, Inc. |
| INKT | MiNK Therapeutics, Inc. |
| TPST | Tempest Therapeutics, Inc. |
| VINC | Vincerx Pharma, Inc. |
| CRIS | Curis, Inc. |
| ATXI | Avenue Therapeutics, Inc. |
| KZR | Kezar Life Sciences, Inc. |
| CBIO | Gyre Therapeutics, Inc. |
| ALRN | Aileron Therapeutics, Inc. |
| FBRX | Forte Biosciences, Inc. |
| GRTX | Galera Therapeutics, Inc. |
NMTR Ownership FAQ
Who Owns 9 Meters Biopharma?
9 Meters Biopharma is owned by institutional shareholders (0.00%), insiders (1.71%), and public (98.29%). The largest institutional shareholder of 9 Meters Biopharma is SABBY MANAGEMENT, LLC (8.52% of total shares) and the top mutual fund owner is DEUTSCHE DWS INVESTMENTS VIT FUNDS (0.05% of total shares).
Who are the major institutional shareholders of 9 Meters Biopharma?
9 Meters Biopharma's major institutional shareholders are SABBY MANAGEMENT, LLC, SIMPLEX TRADING, LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., VANGUARD GROUP INC, and SUSQUEHANNA INTERNATIONAL GROUP, LLP. The top five shareholders own together 27.51% of the company's share outstanding.
How many 9 Meters Biopharma shareholders are there?
As of Dec 2022, there are 1 institutional shareholders of 9 Meters Biopharma.
What percentage of 9 Meters Biopharma is owned by SABBY MANAGEMENT, LLC?
SABBY MANAGEMENT, LLC owns 1.1M shares of 9 Meters Biopharma, representing 8.52% of the company's total shares outstanding, valued at $1.53B (as of Mar 2023).
What percentage of 9 Meters Biopharma is owned by SIMPLEX TRADING, LLC?
As of Mar 2023, SIMPLEX TRADING, LLC holds 699.5K shares of 9 Meters Biopharma (NMTR), compromising 5.40% of the company, valued at $972K.
What percentage of 9 Meters Biopharma is owned by ADAGE CAPITAL PARTNERS GP, L.L.C?
ADAGE CAPITAL PARTNERS GP, L.L.C is the third largest holder of 9 Meters Biopharma. The company owns 650K of the company's shares outstanding (worth $903.5M).